Rani Therapeutics Holdings, Inc. – NASDAQ:RANI
Rani Therapeutics Holdings stock price today
$0.543
-0.87
-61.74%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
Rani Therapeutics Holdings stock price monthly change
-61.62%
month
Rani Therapeutics Holdings stock price quarterly change
-61.62%
quarter
Rani Therapeutics Holdings stock price yearly change
-57.86%
year
Rani Therapeutics Holdings key metrics
Market Cap | 86.70M |
Enterprise value | 135.86M |
P/E | -4.93 |
EV/Sales | N/A |
EV/EBITDA | -3.21 |
Price/Sales | N/A |
Price/Book | 3.59 |
PEG ratio | 0.02 |
EPS | -1.29 |
Revenue | N/A |
EBITDA | -61.21M |
Income | -33.08M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRani Therapeutics Holdings stock price history
Rani Therapeutics Holdings stock forecast
Rani Therapeutics Holdings financial statements
| Jun 2023 | 0 | -9.30M | |
|---|---|---|---|
| Sep 2023 | 0 | -9.19M | |
| Dec 2023 | 2.75M | -7.09M | -258.11% |
| Mar 2024 | 0 | -7.48M |
| Dec 2023 | 2.75M | -7.09M | -258.11% |
|---|---|---|---|
| Mar 2024 | 0 | -7.48M | |
| Oct 2025 | 0 | -19.00M | |
| Dec 2025 | 0 | -18.22M |
Analysts Price target
Financials & Ratios estimates
| 2024-03-20 | -0.31 | -0.27 |
|---|---|---|
| 2024-05-06 | -0.23 | -0.29 |
| Jun 2023 | 83507000 | 35.33M | 42.32% |
|---|---|---|---|
| Sep 2023 | 70436000 | 35.61M | 50.57% |
| Dec 2023 | 57916000 | 32.47M | 56.07% |
| Mar 2024 | 53512000 | 38.97M | 72.84% |
| Jun 2023 | -12.30M | 789K | 80 |
|---|---|---|---|
| Sep 2023 | -14.30M | 11.67M | 49 |
| Dec 2023 | -12.47M | 13.27M | 96 |
| Mar 2024 | -9.40M | 10.29M | 121K |
Rani Therapeutics Holdings alternative data
| Aug 2023 | 163 |
|---|---|
| Sep 2023 | 163 |
| Oct 2023 | 163 |
| Nov 2023 | 163 |
| Dec 2023 | 163 |
| Jan 2024 | 163 |
| Feb 2024 | 163 |
| Mar 2024 | 140 |
| Apr 2024 | 140 |
| May 2024 | 140 |
| Jun 2024 | 140 |
| Jul 2024 | 140 |
Rani Therapeutics Holdings other data
100.00%
+87.95%
of RANI is owned by hedge funds
20
-14
1.28M
-1.66M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Oct 2024 | 0 | 3829360 |
| Dec 2024 | 10296 | 0 |
| Quarter | Transcript |
|---|---|
| Q4 2023 20 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q4 2022 22 Mar 2023 | Q4 2022 Earnings Call Transcript |
| Q4 2021 29 Mar 2022 | Q4 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Dr. Mir Hashim (1959) Chief Scientific Officer | $485,530 |
| Mr. Svai S. Sanford (1970) Chief Financial Officer | $442,560 |
-
What's the price of Rani Therapeutics Holdings stock today?
One share of Rani Therapeutics Holdings stock can currently be purchased for approximately $0.54.
-
When is Rani Therapeutics Holdings's next earnings date?
Unfortunately, Rani Therapeutics Holdings's (RANI) next earnings date is currently unknown.
-
Does Rani Therapeutics Holdings pay dividends?
No, Rani Therapeutics Holdings does not pay dividends.
-
How much money does Rani Therapeutics Holdings make?
Rani Therapeutics Holdings has a market capitalization of 86.70M. Rani Therapeutics Holdings made a loss 33.97M US dollars in net income (profit) last year or -$0.29 on an earnings per share basis.
-
What is Rani Therapeutics Holdings's stock symbol?
Rani Therapeutics Holdings, Inc. is traded on the NASDAQ under the ticker symbol "RANI".
-
What is Rani Therapeutics Holdings's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Rani Therapeutics Holdings?
Shares of Rani Therapeutics Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Rani Therapeutics Holdings's key executives?
Rani Therapeutics Holdings's management team includes the following people:
- Dr. Mir Hashim Chief Scientific Officer(age: 66, pay: $485,530)
- Mr. Svai S. Sanford Chief Financial Officer(age: 55, pay: $442,560)
-
How many employees does Rani Therapeutics Holdings have?
As Jul 2024, Rani Therapeutics Holdings employs 140 workers.
-
When Rani Therapeutics Holdings went public?
Rani Therapeutics Holdings, Inc. is publicly traded company for more then 4 years since IPO on 30 Jul 2021.
-
What is Rani Therapeutics Holdings's official website?
The official website for Rani Therapeutics Holdings is ranitherapeutics.com.
-
Where are Rani Therapeutics Holdings's headquarters?
Rani Therapeutics Holdings is headquartered at 2051 Ringwood Avenue, San Jose, CA.
-
How can i contact Rani Therapeutics Holdings?
Rani Therapeutics Holdings's mailing address is 2051 Ringwood Avenue, San Jose, CA and company can be reached via phone at +40 84573700.
Rani Therapeutics Holdings company profile:
Rani Therapeutics Holdings, Inc.
ranitherapeutics.comExchange:
NASDAQ
Full time employees:
140
Industry:
Biotechnology
Sector:
Healthcare
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.
2051 Ringwood Avenue
San Jose, CA 95131
San Jose, CA 95131
CIK: 0001856725
ISIN: US7530181004
CUSIP: 753018100
